ArticleHeliyon2024
Nanoencapsulation of limonene in octenyl succinic anhydride-modified starch (OSA-ST) and maltodextrin: Investigation and comparison of physicochemical properties, efficiency and morphology of nanoparticles.
Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In recent years, the application of nanoencapsulation has attracted enormous attention for various food and pharmaceutical purposes. In this study, a functional powder containing limonene (the nutraceutical at concentration of 5 and 10 %) was prepared using octenyl succinic anhydride-modified starch (OSA-ST) and maltodextrin as carriers at 15 and 30 %. The emulsions were sonicated at a frequency of 30 kHz and a power of 100 W for 9 and 18 min, and the final nanoparticles were prepared through freeze-drying. The particle sizes were in the ranges of 62-248 and 10-24 nm in the suspensions of OSA and maltodextrin, respectively. The smaller particles of the maltodextrin-prepared sample resulted in more transparency. The zeta potential and consequently the stability of the maltodextrin-prepared emulsions were higher than those of the OSA-ST-prepared ones. As the maltodextrin concentration increased, this parameter was elevated from -42 to -36 as a result of the coverage of the surface-active lipids. The results of solubility correlated with those of the zeta potential (89.21 % for maltodextrin-prepared and 82.51 % for OSA-ST-prepared samples). The highest encapsulation efficiency (EE = 0.9) belonged to the samples prepared with OSA-ST. Comparison of the scanning electron microscopy (SEM) images revealed that the type of the wall material influenced the physical structure of the nanoparticles which were mostly porous and flake-like. Considering its encapsulating-emulsifying properties, OSA-ST can be suggested as a carrier for limonene with the need for emulsifiers.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.